arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Harmony Biosciences Holdings, Inc.

HRMY

$40.52 ▼ -1.02 (-2.46%) at close

8 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

Harmony Biosciences Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.3B

Dividend Yield —

Revenue Growth 21.5% ↘

Op. Margin 24.0% ↘

ROIC 14.9% ↘

FCF / Share $6.05 ↗

Trailing P/E 14.7x

Price / Book 2.7x

FCF Yield 14.9%

Debt / Equity 0.19

info Valuation on last close. End-of-day price, Sep 23, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$868.45M

↑ +21.5% —

Net Income Profit after all expenses

$158.69M

↑ +9.1% —

Operating Margin Operating profit as % of sales

24.0%

↓ -10.1% 80th

FCF / Share Free cash flow per share

$6.05

↑ +57.4% —

Long-Term Debt Long-term obligations

$163.66M

↓ -8.7% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↑

Returns →

Financial Health →

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	21.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+169%)	22.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+185%)	32.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+312%)	43.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+442%)	91.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1040%)	2564.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31957%)	—	—
EPS Growth YoY (%)	7.8% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	18.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-29.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	411.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	89.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	9.1% Fair ↓ Fair Declining Year-over-year change in net income	12.9% Fair ↓ Fair Declining Year-over-year change in net income	-29.0% Weak ↓ Weak Declining Year-over-year change in net income	424.5% Excellent Excellent Year-over-year change in net income	N/M	75.7% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	57.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	4.3% Caution ↓ Caution Declining Year-over-year change in free cash flow	51.1% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	42.8% Excellent Excellent Year-over-year change in free cash flow	N/M	98.8% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	25.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	32.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	53.9% Excellent Excellent Compound annual revenue growth over 3 years	318.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	40.3% Excellent Excellent Compound annual revenue growth over 5 years	160.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	-3.5% Weak Weak Compound annual EPS growth over 3 years	62.2% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	24.0% Good ↓ Good Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+60%)	26.7% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+78%)	33.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+120%)	27.4% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+83%)	28.7% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+91%)	10.6% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-29%)	—	—
Effective Tax Rate (%) (%)	26.2% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.1% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	25.7% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-73.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	18.3% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+52%)	20.4% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+70%)	22.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+84%)	41.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+245%)	11.3% Fair Fair Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6%)	-23.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-293%)	—	—
FCF Margin (%) (%)	40.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	30.6% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	37.6% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	33.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	32.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-1.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	2.19x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.50x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.84x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	14.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	17.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	35.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	21.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	4.6% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	35.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	16.4% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	19.1% Excellent ↓ Excellent Declining Operating profit relative to total assets Optimal: > 10%	23.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	17.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	20.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	4.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-136.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	18.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	22.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+47%)	27.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+84%)	45.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+200%)	18.5% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+24%)	-38.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-353%)	35.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+140%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	0.19x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	0.27x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-55%)	0.41x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-31%)	0.48x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21%)	1.02x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+70%)	2.00x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+233%)	-0.23x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-139%)	—
Interest Coverage (x)	14.23x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	10.91x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	8.08x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	6.39x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	3.62x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	0.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	-34.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-588.84M	$-273.74M	$-118.09M	$-52.14M	$-44.33M	$-34.38M	$73.49M	—
Debt / EBITDA (x)	0.79x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.94x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.01x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.59x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.16x Fair ↓ Fair Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	11.18x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.67x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$15.11	$12.56	$9.79	$7.40	$5.31	$6.20	$0.77	—
Basic EPS, GAAP (USD)	$2.76	$2.56	$2.17	$3.07	$0.60	$-2.48	$-24.07	—
Free Cash Flow per Share (USD)	$6.05	$3.84	$3.68	$2.44	$1.71	$-0.12	$-9.72	—
Book Value per Share (USD)	$15.07	$11.53	$8.23	$6.76	$3.17	$1.71	$-54.30	—
Tangible Book Value per Share (USD)	$13.53	$9.55	$5.81	$4.06	$0.72	$-1.15	$-63.57	—
Basic Weighted Avg Shares (shares)	57.49M	56.89M	59.47M	59.17M	57.53M	25.77M	7.78M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$654.88M	$404.17M	$287.29M	$321.40M	$230.66M	$128.35M	$11.61M	—
LT Debt (USD)	$163.66M	$179.27M	$193.57M	$191.65M	$189.98M	$194.25M	$97.95M	—
Total Equity (USD)	$870.22M	$659.15M	$466.99M	$402.84M	$186.51M	$97.18M	$-422.86M	$-242.67M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$868.45M	$714.73M	$582.02M	$437.86M	$305.44M	$159.74M	$6.00M	—
Depreciation Expense (USD)	—	$267.00K	$514.00K	$419.00K	$416.00K	$394.00K	$395.00K	—
Net Income, GAAP (USD)	$158.69M	$145.49M	$128.85M	$181.47M	$34.60M	$-36.94M	$-151.98M	—
Operating Cash Flow (USD)	$348.20M	$219.82M	$219.39M	$144.47M	$98.56M	$-2.98M	$-75.44M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 30 quarters

Harmony Biosciences Holdings, Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HRMY with peers